Gribaudo et al. established a network of healthy human neurons in a cortical neuron network of microfluidic devices to find that α-synuclein multiplies between neurons in a dose- and structure-dependent manner, triggering PD-like pathology [122]. This evidence concerns the gene SNCA and Parkinson disease.